These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 24116110)

  • 41. Long non-coding RNA LINC01963 inhibits progression of pancreatic carcinoma by targeting miR-641/TMEFF2.
    Li K; Han H; Gu W; Cao C; Zheng P
    Biomed Pharmacother; 2020 Sep; 129():110346. PubMed ID: 32559621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
    Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
    J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3.
    Zhao G; Zhang JG; Shi Y; Qin Q; Liu Y; Wang B; Tian K; Deng SC; Li X; Zhu S; Gong Q; Niu Y; Wang CY
    PLoS One; 2013; 8(9):e73803. PubMed ID: 24040078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C
    Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer.
    Kong Y; Li Y; Luo Y; Zhu J; Zheng H; Gao B; Guo X; Li Z; Chen R; Chen C
    Mol Cancer; 2020 May; 19(1):82. PubMed ID: 32366257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.
    Bhatti I; Lee A; James V; Hall RI; Lund JN; Tufarelli C; Lobo DN; Larvin M
    J Gastrointest Surg; 2011 Jan; 15(1):199-208. PubMed ID: 21088996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2.
    Lu J; He ML; Wang L; Chen Y; Liu X; Dong Q; Chen YC; Peng Y; Yao KT; Kung HF; Li XP
    Cancer Res; 2011 Jan; 71(1):225-33. PubMed ID: 21199804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
    Zhang J; Zhao CY; Zhang SH; Yu DH; Chen Y; Liu QH; Shi M; Ni CR; Zhu MH
    Oncol Rep; 2014 Mar; 31(3):1157-64. PubMed ID: 24398877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
    Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF
    Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor suppressive role of miR-33a-5p in pancreatic ductal adenocarcinoma cells by directly targeting RAP2A.
    Lian Y; Jiang D; Sun J
    Cell Mol Biol Lett; 2021 Jun; 26(1):24. PubMed ID: 34090323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway.
    Mo SJ; Liu X; Hao XY; Chen W; Zhang KS; Cai JP; Lai JM; Liang LJ; Yin XY
    Cancer Lett; 2016 Oct; 380(2):403-412. PubMed ID: 27378242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma.
    Liu L; Qi Y; Huang D; Xu Y; Li M; Hong Z; Gu Y; Jia B; Luo X; Zhang S; Zhang S
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma.
    Liu Q; Chen J; Wang J; Amos C; Killary AM; Sen S; Wei C; Frazier ML
    Mol Carcinog; 2014 Sep; 53(9):711-21. PubMed ID: 23661430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
    Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
    Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294/c-Myc axis.
    Rong Z; Shi S; Tan Z; Xu J; Meng Q; Hua J; Liu J; Zhang B; Wang W; Yu X; Liang C
    Mol Cancer; 2021 Aug; 20(1):106. PubMed ID: 34419070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-497 inhibits cell proliferation and invasion ability by targeting HMGA2 in pancreatic ductal adenocarcinoma.
    Zhou ZG; Xu C; Dong Z; Wang YP; Duan JY; Yan CQ
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):122-129. PubMed ID: 31957824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer.
    Khan S; Ebeling MC; Zaman MS; Sikander M; Yallapu MM; Chauhan N; Yacoubian AM; Behrman SW; Zafar N; Kumar D; Thompson PA; Jaggi M; Chauhan SC
    Oncotarget; 2014 Sep; 5(17):7599-609. PubMed ID: 25277192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coiled-coil domain containing 68 (CCDC68) demonstrates a tumor-suppressive role in pancreatic ductal adenocarcinoma.
    Radulovich N; Leung L; Ibrahimov E; Navab R; Sakashita S; Zhu CQ; Kaufman E; Lockwood WW; Thu KL; Fedyshyn Y; Moffat J; Lam WL; Tsao MS
    Oncogene; 2015 Aug; 34(32):4238-47. PubMed ID: 25381825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways.
    Chen L; Zheng J; Zhang Y; Yang L; Wang J; Ni J; Cui D; Yu C; Cai Z
    Mol Ther; 2011 Aug; 19(8):1521-8. PubMed ID: 21610700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.